news

Scientists identify protein drug target to potentially treat cataracts

Researchers have shown that a protein named aquaporin can disrupt optical development, leading to cataract formation.

Cataract in eye

A team of international scientists has shown that the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein named aquaporin, responsible for water passage in the lens, disrupts optical development, leading to cataract formation. According to the team, led by scientists at Anglia Ruskin University (ARU), UK, these findings could potentially change the way that cataracts are treated – with potential for drug therapy to replace surgery.

The researchers explain that a cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of aquaporin in the lens that reduces the transmission of light to the retina. A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.

In their study, the researchers spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan. The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light, allowing measurements to be taken with the highest accuracy yet on optical properties of the eye. This led them to the discovery that aquaporin accumulation leads to cataract formation.

 

Access your FREE copy

 


Biomarkers aren’t just supporting drug discovery – they’re driving it

FREE market report

From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.

What you’ll unlock:

  • How biomarkers are guiding dose selection and early efficacy decisions in complex trials
  • Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
  • What makes lab data regulatory-ready and why alignment matters from day one

Explore how biomarkers are shaping early drug development

Access the full report – it’s free!

 

Professor Barbara Pierscionek, lead researcher from the study, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons. Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly. Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”

The study was published in Investigative Ophthalmology & Visual Science

Related conditions

Related organisations

One response to “Scientists identify protein drug target to potentially treat cataracts”

  1. Emily Grunt says:

    This is great news! Hope this will help people to get rid of cataracts sooner.

Leave a Reply

Your email address will not be published. Required fields are marked *